Catalent to manufacture Moderna's personalized cancer vaccine for Ph I/II studies

By Melissa Fassbender contact

- Last updated on GMT

Clinical study of Moderna's mRNA personalized cancer vaccine is expected to begin in 2017. (Image: Catalent)
Clinical study of Moderna's mRNA personalized cancer vaccine is expected to begin in 2017. (Image: Catalent)

Related tags: Vaccine

Catalent has entered into an agreement with Moderna Therapeutics to support the company’s proprietary production process.

Mike Riley, VP and General Manager of Catalent​ Biologics confirmed that the company will be providing cGMP manufacturing of Moderna’s mRNA personalized cancer vaccine for phase I/II clinical studies.

According to the company, clinical study of the vaccine is expected to begin in 2017.

Under the agreement, Catalent will be providing dedicated production capability to accommodate Moderna’s proprietary production process, and support fast turnaround of clinical material​,” Riley told us.

Work will take place at Catalent’s Madison, WI-based facility, which was opened in 2013 to support both flexible cGMP and non-GMP production.

The site features integrated process development and analytical capabilities, including the support of method development, in-process, release and stability testing​,” said Riley.

Additionally, Catalent recently announced an expansion to the facility, which Riley said will create increased capacity for later phase clinical and commercial production.

Related news

Show more

Related products

Innovations in OSD

Innovations in OSD

Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars